NextCure, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/nextcure-inc

Entity: Public listing published
Primary listing: NASDAQ: NXTC
Verification: Partially verified
Last reviewed: 2026-09-02T04:47:29.554842+00:00

Overview

Alpha's canonical identity and public leadership record for NextCure, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

3 public records

Michael Richman

President and Chief Executive Officer

State: confirmed
Effective: From Apr 24, 2026
Confidence: 94%
Evidence: NXTC DEF 14A executive officersApr 24, 2026

Timothy Mayer, Ph.D.

Chief Operating Officer

State: confirmed
Effective: From Apr 24, 2026
Confidence: 94%
Evidence: NXTC DEF 14A executive officersApr 24, 2026

Udayan Guha, M.D., Ph.D.

Chief Medical Officer

State: confirmed
Effective: From Apr 24, 2026
Confidence: 94%
Evidence: NXTC DEF 14A executive officersApr 24, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Board roles

2 public records

Anne Borgman, M.D.

Director

Independent

State: unconfirmed
Effective: From Jan 1, 2021
Confidence: 85%
Evidence: NextCure, Inc. DEF 14A 2026-04-24Apr 24, 2026

John G. Houston, Ph.D.

Director

Independent

State: unconfirmed
Effective: From Jan 1, 2020
Confidence: 85%
Evidence: NextCure, Inc. DEF 14A 2026-04-24Apr 24, 2026

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-09-02T04:47:29.554842+00:00